PreviewDealogy is opening soon. The businesses shown are examples illustrating how the marketplace works, not live opportunities.Join the waitlist
← All businessesLogistics, Transport & Distribution / Medical & Pharma Supplies / Pharmaceutical wholesale

Pharmaceutical Wholesaler Trading In Birmingham Since 2005

Birmingham, West Midlands, West MidlandsIdentity protected

Available

Pharmaceutical wholesaler trading in Birmingham since 2005

About this business

Pharmaceutical wholesaler trading from leased warehouse premises on a Birmingham industrial estate since 2005, supplying pharmacies, dispensing doctors and private clinics across the Midlands. It has 21 employees covering purchasing, quality, warehouse and transport. Turnover has fallen gradually from £12.54m in 2021 to £11m, while EBITDA has risen to £1.44m, so the business is earning more from less. With a settled team and a long trading record, it offers a buyer a large, profitable base in Midlands medicines supply.

Key investment highlights

  • Trading in Birmingham since 2005
  • EBITDA up to £1.44m as sales eased
  • Supplies pharmacies and dispensing doctors
  • Turnover of £11m

Reason for sale

This is a long-planned exit by the founding family, who started it in 2005.

Read this before you enquire

Material

Revenue going backwards and one client being too much of it are the two things that end most deals in due diligence. Both are shown here up front, from the figures the seller supplied.

  • Revenue directionMaterial

    Turnover has fallen in each of the last 4 years, most recently by -2.4%.

    • 2021: baseline
    • 2022 (-1.1%)
    • 2023 (-2.6%)
    • 2024 (-3.2%)
    • 2025 (-3.5%)
    • 2026 (-2.4%)
    • Peak 2021 to latest 2026: -12.3%

    6 years of turnover, 2021 to 2026, as supplied by the seller.

  • Client concentrationNot stated

    The seller has not declared what share of revenue the largest clients represent.

    No declaration supplied. Client concentration cannot be derived from accounts.

EBITDA margin widened from 10.3% in 2021 to 13.1% in 2026.

These are observations from the supplied figures, not a view on whether this business is worth buying. Nothing here predicts an outcome.

Computing valuation...

What happens next

Submit an enquiry to the seller. Once they approve it, you sign a non-disclosure agreement and gain access to the information memorandum, the financials and a secure deal room with the seller.